The Priority Review

Tag

Insulin glargine

1 story

  1. Clinical trials

    Jiangsu HengRui registers Phase 3 trial of SHR-3167 vs insulin glargine

    The study plans to enroll 450 insulin-naive type 2 diabetes participants to compare once-weekly SHR-3167 with once-daily insulin glargine. It is planned to start in November 2026 and complete primary outcomes in October 2027.